DUBLIN, June 20, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021" report to their offering.
The vaccine adjuvants market is forecast to reach a value USD 769.4 Million by 2021.
The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets has opened an array of opportunities for the market. However, the high cost of adjuvant-based research and proven safety of adjuvants are hampering the growth of the global market.
On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High prevalence of infectious diseases and increasing funding for adjuvant research will drive the growth of this market segment.
Based on route of administration, the vaccine adjuvants market includes oral route, subcutaneous route, intranasal route, intramuscular route, intradermal route, and other routes. The intramuscular segment is expected to account for the largest share of the global market in 2016. Rising geriatric population and vaccines for improved immunization are the key factors propelling the growth of this market.
- Agenus, Inc.
- Avanti Polar Lipids, Inc.
- Brenntag Biosector A/S (A Subsidiary of Brenntag AG)
- CSL Limited
- MPV Technologies, Inc.
- Novavax, Inc.
- OZ Biosciences
- SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
- Seppic (A Subsidiary of Air Liquide Group)
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Vaccine Adjuvants Market, By Product Type
7 Global Vaccine Adjuvants Market, By Route of Administration
8 Global Vaccine Adjuvant Market, By Disease Type
9 Global Vaccine Adjuvants Market, By Application
10 Global Vaccine Adjuvants Market, By Application Category
11 Global Vaccine Adjuvants Market, By Region
12 Competitive Landscape
13 Company Profile
For more information visit http://www.researchandmarkets.com/research/3w2b4t/vaccine_adjuvants
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets